Navigation Links
Genta Receives Key Patent Related to Oral Gallium Compound G4544
Date:4/14/2008

Company to Seek Buyer for Marketed Parenteral Product Ganite(R)

BERKELEY HEIGHTS, N.J., April 14 /PRNewswire/ -- Genta Incorporated (Nasdaq: GNTA) today announced that the Company has received notice that its patent application covering novel pharmaceutical gallium compositions and complexes has been allowed by the U.S. Patent Office. Issued U.S. Patent 7,354,952 extends the intellectual property surrounding the Company's franchise of oral gallium-containing products that are intended as potential treatment for diseases associated with accelerated bone loss. The lead compound in this investigational pipeline, G4544, was developed in collaboration with Emisphere Technologies, Inc. (Nasdaq: EMIS) and has completed its initial Phase 1 dose-ranging study. Results of this study will be presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) that takes place in Chicago, IL from May 30-June 3, 2008.

With continued progress in the oral formulation program, the Company has elected to seek a buyer for the intravenous formulation of its on-market product from this franchise, Ganite(R) (gallium nitrate injection). The active ingredient in both Ganite and G4544 is ionic gallium, which is reversibly incorporated into bone where its acts as a potent inhibitor of bone resorption and possibly as a mild anabolic agent to enhance bone formation. Ganite is approved by the U.S. Food and Drug Administration for treatment of patients with cancer-related hypercalcemia that is resistant to hydration
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
3. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
4. Genta Incorporated Announces Third Quarter 2007 Financial Results
5. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
6. Genta Clinical Programs Featured at American Society of Hematology Meeting
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
10. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
11. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 2014   Royal Philips  (NYSE: PHG, AEX: PHIA) ... new ultrasound system designed to enable global hospitals and ... volumes and cost pressures. Making its debut at the  ... Barcelona this week, Affiniti provides innovative ... fewer resources deliver high quality patient care. ...
(Date:8/29/2014)... CHAPEL HILL, N.C. , Aug. 29, 2014 /PRNewswire/ ... Opinion Leaders (KOLs) can be the difference between a ... struggle to effectively map and stratify KOL targets – ... to build the type of strong relationships upon which ... recent research, savvy pharma companies have identified internal inconsistencies ...
(Date:8/29/2014)... YORK , Aug. 29, 2014 Pomerantz ... TMS S.A. ("EDAP" or the "Company") (NASDAQ: EDAP ... filed in United States District Court, Southern District of ... 14-cv-6069, is on behalf of a class consisting of ... February 1, 2013 and July 30, 2014, inclusive (the ...
Breaking Medicine Technology:Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4Implementing a Strategic Thought Leader Management & Engagement System 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3
... Addex Pharmaceuticals,announced today the successful completion of ... its lead compound ADX10059 in patients with,gastro-esophageal ... a significant unmet medical need. The study ... esophageal pH, with,statistical significance, and also showed ...
... in Blood Highlight Millennium Leadership in,Personalized Medicine and ... Therapy in Broad Range of Multiple Myeloma Patients ... published in the April 15th issue of Blood ... Pharmaceuticals, Inc. has,discovered biomarkers which may lead to ...
Cached Medicine Technology:Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 2Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 3Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 4Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease 5Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 2Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 3Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 4Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 5Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 6
(Date:8/30/2014)... Serving contented clients since inception, #1 ... Outsourcing is now offering discount for Labor Day ... emphasize on putting forward the best of web development ... dedicated team of professionals and web developers and designers ... even the critical issues of web development and can ...
(Date:8/30/2014)... PA (PRWEB) August 30, 2014 "I had ... because of her crutches," said an inventor from Wetumpka, Ala. ... sights and sounds of the shore, I came up with ... sand." , She created a prototype for the patent-pending Deezers ... accessory enables the individual to use crutches, walkers, or canes ...
(Date:8/30/2014)... In today’s world, a good night’s ... get. Snoring and sleep apnea (a medical problem where ... people and their bed partners of the rest they ... of the population snores and 20 million people in ... only 10% have been diagnosed and treated; and of ...
(Date:8/30/2014)... The new review published by Daily Gossip reveals ... Brimeyer, who wanted to make her guide accessible to sufferers ... now easy to find in the form of an eBook, ... author of the new method shares all her tips and ... in its review that the leaky gut syndrome can be ...
(Date:8/30/2014)... LiveStreamingFitness.com, a company dedicated to providing live ... resources, is proud to announce it has been recognized as ... fitness solutions by ABC’s Good Morning America. ... Good Morning America, “Live Streaming Fitness is the hottest new ... by streamlining your workout…to boot camp at Life Streaming Fitness ...
Breaking Medicine News(10 mins):Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2Health News:LiveStreamingFitness.com is New Trend In Fitness 2
... spent socializing raised peoples, test scores, researchers say , ... gab could boost brainpower, new research suggests. , A ... 10 minutes a day improves memory and test scores. ... as more traditional kinds of mental exercise in boosting ...
... toddler years, study finds , FRIDAY, Nov. 16 (HealthDay News) ... how a child,s nervous system will develop through its toddler ... National Institutes of Health researchers checked fetal heart rate and ... decreases within a specific time period -- six times from ...
... Speaker Nancy Pelosi,will join Congressmen Ciro D. ... to discuss the State Children,s Health,Insurance Program (SCHIP) ... children., WHO: Speaker Nancy Pelosi Congressman ... (TX-20) Congressman Henry Cuellar (TX-28), WHAT: ...
... America,s Seniors, WASHINGTON, Nov. 16 A ... (OIG) finding that in Medicare Part D,generic drugs ... generic,substitutes were available and that 56 percent of ... benefit manager (PBM) tools are,driving down prescription drug ...
... Cancer Early Detection and,Treatment Research Trust Fund, WASHINGTON, ... Susan Fargo, the Senate Chair of the Joint,Committee on ... for lung cancer research., "This is a watershed ... those at risk for the disease in Massachusetts," said ...
... WASHINGTON, Nov. 16 House Republican Whip,Roy Blunt ... alleged "compromise" offer to reduce their spending demands ... Democrats offered to ,compromise, and reduce their demand,for ... billion.,Interestingly, this offer did not include anything about ...
Cached Medicine News:Health News:Talking With Others May Make You Smarter 2Health News:Fetal Heart Rate Points to Later Child Development 2Health News:New OIG Report Confirms Part D Plans Are Driving Generic Utilization 2Health News:Lung Cancer Alliance Hails Massachusetts Senator for Taking Lead on Lung Cancer Legislation 2
This fixed-volume digital micropipet is used to accurately measure and transfer 5 microliters of solution....
... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
10L...
... ergonomics, and value!, Comfortable feel ... non-slip, contoured handle , Finer control ... spring action , Completely autoclavable for ... need for recalibration , Easy-to-read precision ...
Medicine Products: